GASTROINTESTINAL ENDOSCOPY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2023-07-31 天元湖大鲤鱼来自江苏省

各位decision in process一般持续多久？

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2023-07-11 ms3000001727854429 来自四川省

偏重的研究方向：消化;内镜
经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢#期刊论坛#

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2023-04-14 ms9000000258853141 来自四川省

想问一下该期刊收个案不？可以选原创文章投吗？

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2022-07-21 sky110319

请教各位大神，With Editor一周，不知道是什么情况？

58 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2019-12-03 123eca1fm35暂无昵称

这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表:
被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。

158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。

167 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2022-04-15 ms6000000285996390

想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2020-01-29 14820e9am86暂无昵称

请问投稿要求，格式之类的应该怎么知道呢？感谢

162 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2021-11-12 doctor10

偏重的研究方向：内镜;临床
经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长

89 0

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2019-11-24 147a5940m05暂无昵称

投稿命中率:25.0
经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。

173 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2147517, encodeId=34d5214e51734, content=偏重的研究方向：消化;内镜 经验分享：这杂志投meta是不是基本都被曾刊或摘要，很多文章在WOS里都搜不到呢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Tue Jul 11 19:31:20 CST 2023, time=2023-07-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125967, encodeId=8b57212596eae, content=想问一下该期刊收个案不？可以选原创文章投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46988600689, createdName=ms9000000258853141, createdTime=Fri Apr 14 20:39:51 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神，With Editor一周，不知道是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关？158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家，GIE的具体要求和格式是什么？是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583966, encodeId=ac7e58396691, content=请问投稿要求，格式之类的应该怎么知道呢？感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24be5270720, createdName=14820e9am86暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向：内镜;临床 经验分享：美国消化内镜学会会刊，相比endoscopy，article和review(meta分析)的发表量要更多，中国人文章出现的频率也要高很多。总体来说关注这么多年，也投了N次(虽然没中几次)，感觉对创新性的要求比较高，其次是方法，再次是样本量。一审很快，article和review基本送审一个多月都会审回来，但是整个流程很消耗时间，因为编辑一般都会决定很久，decision in process持续N天，最后还是拒搞。case，letter一般是两周左右给结果，但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580345, encodeId=995e58034583, content=投稿命中率:25.0 经验分享：被AJG拒稿，按照审稿意见仔细修改，改投GIE一审一个多月，大修返修后大概20天直接接收，article，mark一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Sun Nov 24 00:00:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970707, encodeId=fbcd9e0707ff, content=中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:50:45 CST 2021, time=2021-06-03, status=1, ipAttribution=)]

2021-06-03 147a5f5cm41(暂无昵称)

中了一篇image 说实话这个杂志相当不错，不愧是内镜的顶刊，之前投过一篇临床论著送外审后拒稿，审稿人相当负责，提了相当多但是有意义的意见，将近4张A4纸良心杂志

78 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务